Literature DB >> 17177299

Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.

Fangping He1, Xing Wang, Bin He, Zongdi Feng, Xiaomei Lu, Yaoxin Zhang, Shujun Zhao, Renyong Lin, Yan Hui, Yongxing Bao, Zhaoxia Zhang, Hao Wen.   

Abstract

Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus, is etiologically associated with Kaposi's sarcoma and other lymphoproliferative diseases. Although HHV-8 prevalence exhibits considerable variation in different geographic regions and populations, the incidence of Kaposi's sarcoma appear to increase in areas with a high prevalence rate. In this study, an enzyme-linked immunosorbent assay based on mixed antigens of HHV-8 ORF(73), ORF(65), and K8.1 in the antigenic region was established and used to determine viral prevalence estimates and risk factors associated with HHV-8 infection. Of 482 tumor patients studied, the overall seropositivity of HHV-8 was 25.5%. Notably, Han people, who were immigrants or descendents of immigrants from inland of China, exhibited 26.4% seropositivity. This is similar to that observed in Uygur people, a local ethnic group with a high prevalence of HHV-8 infection and incidence of Kaposi's sarcoma. While there was no significant difference in patients with different tumors, HHV-8 seroprevalence was higher in individuals with malignant diseases. Logistic regression analysis suggests that the age is a risk factor associated with HHV-8 infection, with prevalence increasing from 12.5% under 20-27.5% above 50. These results suggest that unlike other parts of mainland of China, Xinjiang is an area with a high prevalence of HHV-8 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177299     DOI: 10.1002/jmv.20730

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors.

Authors:  Xing Wang; Bin He; Zhaoxia Zhang; Tao Liu; Hui Wang; Xu Li; Qiong Zhang; Ke Lan; Xiaomei Lu; Hao Wen
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

2.  High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China.

Authors:  Y Cao; V Minhas; X Tan; J Huang; B Wang; M Zhu; Y Gao; T Zhao; L Yang; C Wood
Journal:  Clin Microbiol Infect       Date:  2013-08-28       Impact factor: 8.067

Review 3.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

4.  The expression profiles of microRNAs in Kaposi's sarcoma.

Authors:  Xiu-Juan Wu; Xiong-Ming Pu; Zong-Feng Zhao; Ya-Nan Zhao; Xiao-Jing Kang; Wei-Dong Wu; Yun-Min Zou; Cao-Ying Wu; Yuan-Yuan Qu; De-Zhi Zhang; Yan-Yan Feng; Jian-Yong Liu
Journal:  Tumour Biol       Date:  2014-10-01

5.  Prevalence of human herpesvirus 8 and hepatitis C virus in a rural community with a high risk for blood-borne infections in central China.

Authors:  T Zhang; N He; Y Ding; K Crabtree; V Minhas; C Wood
Journal:  Clin Microbiol Infect       Date:  2011-03       Impact factor: 8.067

6.  Antibody responses to lytic and latent human herpesvirus 8 antigens among HIV-infected patients in central China.

Authors:  T J Zhang; N He; Y Y Ding; Q W Jiang; C Wood
Journal:  Biosci Trends       Date:  2012-06       Impact factor: 2.400

7.  Virological and molecular characterization of Kaposi's sarcoma-associated herpesvirus strains from Xinjiang, China.

Authors:  X Wang; H Wang; B He; Y Hui; G Lv; L Li; H Wen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-03       Impact factor: 3.267

8.  Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies.

Authors:  Veenu Minhas; Lynsey N Crosby; Kay L Crabtree; Saul Phiri; Tendai J M'soka; Chipepo Kankasa; William J Harrington; Charles D Mitchell; Charles Wood
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

9.  Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era.

Authors:  Owen Ngalamika; Veenu Minhas; Charles Wood
Journal:  Int J Cancer       Date:  2014-09-18       Impact factor: 7.396

10.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.

Authors:  Bishi Fu; Feng Sun; Baolin Li; Lei Yang; Yan Zeng; Xiulian Sun; Fanhong Xu; Simon Rayner; Moraima Guadalupe; Shou-Jiang Gao; Linding Wang
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.